Astrazeneca PLC (AZN) Earns "Neutral" Rating from JPMorgan Chase & Co.


Other hedge funds and institutional investors recently modified their holdings of the company. Logan Capital Management Inc. increased its position in shares of Astrazeneca PLC by 0.6% in the first quarter.



from Biotech News